|
G |
B3gat1 |
beta-1,3-glucuronyltransferase 1 |
multiple interactions |
ISO |
[bromodichloromethane co-treated with Dietary Fats] results in increased expression of B3GAT1 protein |
CTD |
PMID:24211274 |
|
NCBI chr 8:25,087,123...25,114,692
Ensembl chr 8:25,087,547...25,113,395
|
|
G |
Casp3 |
caspase 3 |
multiple interactions |
ISO |
[bromodichloromethane co-treated with Dietary Fats] results in increased expression of CASP3 protein modified form; [PRF1 protein co-treated with RAG2 protein] affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of CASP3 protein modified form]; LEP protein affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of CASP3 protein modified form] |
CTD |
PMID:24211274 |
|
NCBI chr16:45,662,910...45,681,171
Ensembl chr16:45,662,910...45,684,648
|
|
G |
Ccl2 |
C-C motif chemokine ligand 2 |
multiple interactions |
ISO |
bromodichloromethane promotes the reaction [Dietary Fats results in increased expression of CCL2 protein] |
CTD |
PMID:23438451 |
|
NCBI chr10:67,005,424...67,007,222
Ensembl chr10:67,005,424...67,007,226
|
|
G |
Ccnd1 |
cyclin D1 |
increases expression |
EXP |
bromodichloromethane results in increased expression of CCND1 mRNA |
CTD |
PMID:24001804 |
|
NCBI chr 1:200,089,002...200,098,524
Ensembl chr 1:200,089,002...200,098,602
|
|
G |
Cd68 |
Cd68 molecule |
multiple interactions |
ISO |
[Dietary Fats co-treated with bromodichloromethane] results in increased expression of CD68 mRNA; gadolinium chloride inhibits the reaction [[Dietary Fats co-treated with bromodichloromethane] results in increased expression of CD68 mRNA] |
CTD |
PMID:23438451 |
|
NCBI chr10:54,381,814...54,383,693
Ensembl chr10:54,381,815...54,383,697
|
|
G |
Cdh1 |
cadherin 1 |
decreases expression increases methylation |
EXP |
bromodichloromethane results in decreased expression of CDH1 mRNA; bromodichloromethane results in decreased expression of CDH1 protein bromodichloromethane results in increased methylation of CDH1 gene |
CTD |
PMID:24001804 |
|
NCBI chr19:34,492,371...34,561,775
Ensembl chr19:34,492,371...34,561,775
|
|
G |
Cyp1a2 |
cytochrome P450, family 1, subfamily a, polypeptide 2 |
increases metabolic processing decreases expression increases expression affects metabolic processing multiple interactions |
ISO EXP |
CYP1A2 protein results in increased metabolism of bromodichloromethane bromodichloromethane results in decreased expression of CYP1A2 protein bromodichloromethane results in increased expression of CYP1A2 protein CYP1A2 protein affects the metabolism of bromodichloromethane isosafrole inhibits the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane]; Tetrachlorodibenzodioxin promotes the reaction [CYP1A2 protein affects the metabolism of bromodichloromethane] |
CTD |
PMID:11295256 PMID:12062927 PMID:12076521 |
|
NCBI chr 8:58,075,367...58,082,255
Ensembl chr 8:58,075,367...58,082,312
|
|
G |
Cyp2b1 |
cytochrome P450, family 2, subfamily b, polypeptide 1 |
increases expression increases metabolic processing decreases expression |
EXP |
bromodichloromethane results in increased expression of CYP2B1 protein CYP2B1 protein results in increased metabolism of bromodichloromethane bromodichloromethane results in decreased expression of CYP2B1 protein |
CTD |
PMID:11295256 PMID:12076521 |
|
NCBI chr 1:81,518,387...81,544,999
Ensembl chr 1:81,518,408...81,542,052
|
|
G |
Cyp2b2 |
cytochrome P450, family 2, subfamily b, polypeptide 2 |
increases metabolic processing |
EXP |
CYP2B2 protein results in increased metabolism of bromodichloromethane |
CTD |
PMID:12076521 |
|
NCBI chr 1:81,594,534...81,608,567
Ensembl chr 1:81,594,555...81,608,566
|
|
G |
Cyp2e1 |
cytochrome P450, family 2, subfamily e, polypeptide 1 |
multiple interactions decreases response to substance increases metabolic processing increases expression |
EXP ISO |
CYP2E1 protein results in increased metabolism of and results in increased activity of bromodichloromethane [Dietary Fats co-treated with bromodichloromethane] results in increased expression of CYP2E1 protein; CYP2E1 protein affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IFNG mRNA]; CYP2E1 protein affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IL1B mRNA]; CYP2E1 protein affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IL2 mRNA]; CYP2E1 protein affects the susceptibility to [bromodichloromethane co-treated with Dietary Fats] CYP2E1 gene mutant form results in decreased susceptibility to bromodichloromethane CYP2E1 protein results in increased metabolism of bromodichloromethane bromodichloromethane results in increased expression of CYP2E1 protein |
CTD |
PMID:9458004 PMID:11295256 PMID:12076521 PMID:12076522 PMID:18350910 PMID:23438451 PMID:23640861 PMID:24211274 More...
|
|
NCBI chr 1:195,840,330...195,850,728
Ensembl chr 1:195,840,058...195,864,023
|
|
G |
Cyp3a2 |
cytochrome P450, family 3, subfamily a, polypeptide 2 |
increases metabolic processing |
ISO |
CYP3A4 protein results in increased metabolism of bromodichloromethane |
CTD |
PMID:12076521 |
|
NCBI chr12:9,207,978...9,230,064
Ensembl chr12:9,015,383...9,285,008
|
|
G |
Gpt |
glutamic--pyruvic transaminase |
increases expression |
ISO |
bromodichloromethane results in increased expression of GPT |
CTD |
PMID:25640707 |
|
NCBI chr 7:108,416,646...108,419,495
Ensembl chr 7:108,416,642...108,419,494
|
|
G |
Gstt1 |
glutathione S-transferase theta 1 |
increases metabolic processing multiple interactions |
ISO EXP |
GSTT1 protein results in increased metabolism of bromodichloromethane GSTT1 protein affects the metabolism of [bromodichloromethane co-treated with Glutathione] |
CTD |
PMID:12588193 PMID:14998683 |
|
NCBI chr20:12,856,613...12,873,586
Ensembl chr20:12,856,669...12,873,585
|
|
G |
Ifng |
interferon gamma |
multiple interactions |
ISO |
[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IFNG mRNA; CYP2E1 protein affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IFNG mRNA] |
CTD |
PMID:24211274 |
|
NCBI chr 7:53,903,339...53,907,375
Ensembl chr 7:53,903,337...53,907,375
|
|
G |
Il1b |
interleukin 1 beta |
multiple interactions |
ISO |
[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IL1B mRNA; CYP2E1 protein affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IL1B mRNA] |
CTD |
PMID:24211274 |
|
NCBI chr 3:116,577,005...116,583,386
Ensembl chr 3:116,577,010...116,583,415
|
|
G |
Il2 |
interleukin 2 |
multiple interactions |
ISO |
[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IL2 mRNA; [PRF1 protein co-treated with RAG2 protein] affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IL2 mRNA]; CYP2E1 protein affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IL2 mRNA] |
CTD |
PMID:24211274 |
|
NCBI chr 2:120,004,862...120,009,566
Ensembl chr 2:120,004,862...120,009,566
|
|
G |
Jun |
Jun proto-oncogene, AP-1 transcription factor subunit |
decreases expression |
EXP |
bromodichloromethane results in decreased expression of JUN mRNA |
CTD |
PMID:24001804 |
|
NCBI chr 5:109,894,175...109,897,268
Ensembl chr 5:109,893,145...109,897,656
|
|
G |
Lep |
leptin |
increases expression multiple interactions decreases response to substance |
ISO |
bromodichloromethane results in increased expression of LEP mRNA bromodichloromethane promotes the reaction [Dietary Fats results in increased expression of LEP mRNA]; LEP protein affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of CASP3 protein modified form]; LEP protein affects the reaction [[Dietary Fats co-treated with bromodichloromethane] affects the localization of NCF2 protein]; LEP protein results in decreased susceptibility to [Dietary Fats co-treated with bromodichloromethane] LEP gene mutant form results in decreased susceptibility to bromodichloromethane |
CTD |
PMID:23438451 PMID:23640861 PMID:24211274 |
|
NCBI chr 4:57,661,127...57,675,262
Ensembl chr 4:57,661,131...57,675,262
|
|
G |
Lepr |
leptin receptor |
multiple interactions |
ISO |
LEPR protein affects the reaction [[Dietary Fats co-treated with bromodichloromethane] affects the localization of NCF2 protein]; LEPR protein results in decreased susceptibility to [Dietary Fats co-treated with bromodichloromethane] |
CTD |
PMID:23438451 |
|
NCBI chr 5:116,294,409...116,477,904
Ensembl chr 5:116,289,823...116,475,908
|
|
G |
Lhb |
luteinizing hormone subunit beta |
decreases secretion |
EXP |
bromodichloromethane results in decreased secretion of LHB protein |
CTD |
PMID:14657523 PMID:17344021 |
|
NCBI chr 1:95,898,269...95,901,973
Ensembl chr 1:95,900,984...95,901,972 Ensembl chr 1:95,900,984...95,901,972
|
|
G |
Myc |
MYC proto-oncogene, bHLH transcription factor |
decreases methylation increases expression decreases expression |
ISO EXP |
bromodichloromethane results in decreased methylation of MYC promoter bromodichloromethane results in increased expression of MYC mRNA bromodichloromethane results in decreased expression of MYC mRNA |
CTD |
PMID:11099637 PMID:24001804 |
|
NCBI chr 7:93,593,705...93,598,633
Ensembl chr 7:93,593,705...93,598,630
|
|
G |
Ncf2 |
neutrophil cytosolic factor 2 |
multiple interactions |
ISO |
[Dietary Fats co-treated with bromodichloromethane] affects the localization of NCF2 protein; LEP protein affects the reaction [[Dietary Fats co-treated with bromodichloromethane] affects the localization of NCF2 protein]; LEPR protein affects the reaction [[Dietary Fats co-treated with bromodichloromethane] affects the localization of NCF2 protein] |
CTD |
PMID:23438451 |
|
NCBI chr13:64,955,622...64,986,144
Ensembl chr13:64,955,503...64,986,277
|
|
G |
Pcna |
proliferating cell nuclear antigen |
increases expression |
ISO EXP |
bromodichloromethane results in increased expression of PCNA protein |
CTD |
PMID:8717228 PMID:11099637 |
|
NCBI chr 3:119,499,039...119,502,911
Ensembl chr 3:119,498,810...119,502,995
|
|
G |
Prf1 |
perforin 1 |
multiple interactions |
ISO |
[PRF1 protein co-treated with RAG2 protein] affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of CASP3 protein modified form]; [PRF1 protein co-treated with RAG2 protein] affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IL2 mRNA]; [PRF1 protein co-treated with RAG2 protein] affects the susceptibility to [bromodichloromethane co-treated with Dietary Fats] |
CTD |
PMID:24211274 |
|
NCBI chr20:29,246,202...29,251,712
Ensembl chr20:29,246,202...29,251,701
|
|
G |
Rag2 |
recombination activating 2 |
multiple interactions |
ISO |
[PRF1 protein co-treated with RAG2 protein] affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of CASP3 protein modified form]; [PRF1 protein co-treated with RAG2 protein] affects the reaction [[bromodichloromethane co-treated with Dietary Fats] results in increased expression of IL2 mRNA]; [PRF1 protein co-treated with RAG2 protein] affects the susceptibility to [bromodichloromethane co-treated with Dietary Fats] |
CTD |
PMID:24211274 |
|
NCBI chr 3:87,902,373...87,910,227
Ensembl chr 3:87,902,238...87,911,066
|
|
G |
Tnf |
tumor necrosis factor |
multiple interactions |
ISO |
[Dietary Fats co-treated with bromodichloromethane] results in increased expression of TNF protein |
CTD |
PMID:23438451 |
|
NCBI chr20:3,622,011...3,624,629
Ensembl chr20:3,622,011...3,624,629
|
|